Back to Search
Start Over
528MO Is re-introduction or continuation of PARP inhibitors after local therapy for oligo-metastatic progression in patients with relapsed ovarian cancer relevant?
- Source :
- Annals of Oncology. 33:S787-S788
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........949dbd4d6738a22218827bd9dd54bd0d
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.656